WELL Health Technologies (TSE:WELL) Shares Down 13.2% – Time to Sell?

WELL Health Technologies Corp. (TSE:WELL)’s share price fell 13.2% during mid-day trading on Tuesday. The company traded as low as C$3.68 and last traded at C$3.69. Approximately 5,287,784 shares traded hands during mid-day trading, an increase of 297% from the average daily volume of 1,332,669 shares. The stock had previously closed at C$4.25.

Analyst Ratings Changes

Separately, TD set a C$8.50 price target on shares of WELL Health Technologies and gave the company a “buy” rating in a research report on Monday, October 5th. Five equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of C$7.40.

WELL Health Technologies Price Performance

The business’s 50 day moving average price is C$4.24 and its two-hundred day moving average price is C$4.19. The stock has a market cap of C$952.12 million, a P/E ratio of 186.00, a price-to-earnings-growth ratio of -1.93 and a beta of 0.51. The company has a current ratio of 0.80, a quick ratio of 1.02 and a debt-to-equity ratio of 100.05.

WELL Health Technologies (TSE:WELL) last released its earnings results on Monday, November 9th. The company reported C$0.11 EPS for the quarter. The company had revenue of C$407.40 million during the quarter. WELL Health Technologies had a return on equity of 0.44% and a net margin of 0.25%. As a group, sell-side analysts expect that WELL Health Technologies Corp. will post 0.30 earnings per share for the current fiscal year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.